S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
15 A.I. Trading Opportunities a Day (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
15 A.I. Trading Opportunities a Day (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
15 A.I. Trading Opportunities a Day (Ad)
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
ASX:PNV

PolyNovo (PNV) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.38 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlines

PNV stock logo

About PolyNovo (ASX:PNV) Stock

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

PNV Stock News Headlines

May 21, 2023 | finance.yahoo.com
PolyNovo Limited's (ASX:PNV) Intrinsic Value Is Potentially 55% Above Its Share Price
May 11, 2023 | msn.com
PolyNovo (ASX:PNV) Price Target Decreased by 9.30% to 2.29
June 4, 2023 | Legacy Research (Affiliate) (Ad)
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
May 5, 2023 | finance.yahoo.com
When Will PolyNovo Limited (ASX:PNV) Become Profitable?
April 18, 2023 | finance.yahoo.com
PolyNovo Limited (ASX:PNV) Not Flying Under The Radar
March 26, 2023 | americanbankingnews.com
Insider Selling: PolyNovo Limited (ASX:PNV) Insider Sells A$465,322.73 in Stock
March 26, 2023 | americanbankingnews.com
PolyNovo Limited (ASX:PNV) Insider David Williams Sells 305,451 Shares
March 26, 2023 | americanbankingnews.com
PolyNovo Limited (ASX:PNV) Insider Sells A$8,160,000.00 in Stock
June 4, 2023 | Legacy Research (Affiliate) (Ad)
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
March 23, 2023 | fool.com.au
PolyNovo share price falls 17% in two days after major insider selling
March 1, 2023 | msn.com
ASX Market Update, March 1– What You Should Know
February 24, 2023 | finance.yahoo.com
PolyNovo First Half 2023 Earnings: AU$0.006 loss per share (vs AU$0.002 profit in 1H 2022)
February 8, 2023 | msn.com
Why did ASX 300 healthcare stock Polynovo tumble 12% today?
January 25, 2023 | finance.yahoo.com
Is There Now An Opportunity In PolyNovo Limited (ASX:PNV)?
January 17, 2023 | msn.com
Australia stocks lower at close of trade; S&P/ASX 200 down 0.03%
January 10, 2023 | msn.com
2 ASX All Ords shares cracking new 52-week highs on Tuesday
January 5, 2023 | msn.com
Australia stocks higher at close of trade; S&P/ASX 200 up 0.06%
January 5, 2023 | finance.yahoo.com
Investing in PolyNovo (ASX:PNV) five years ago would have delivered you a 278% gain
December 19, 2022 | msn.com
Australia stocks lower at close of trade; S&P/ASX 200 down 0.21%
December 2, 2022 | fool.com.au
Up 30% in 2022: Top broker says the PolyNovo share price can keep rising
November 11, 2022 | finance.yahoo.com
PolyNovo Limited (ASX:PNV) Is About To Turn The Corner
October 27, 2022 | fool.com.au
Guess which ASX All Ords share turned a $30,000 investment into $1 million
October 10, 2022 | finance.yahoo.com
Bullish PolyNovo Limited (ASX:PNV) insiders were rewarded last week as their AU$6.4m investment inflated to AU$9.8m
October 5, 2022 | fool.com.au
PolyNovo share price surges 13% on record quarter
September 22, 2022 | finance.yahoo.com
There's Been No Shortage Of Growth Recently For PolyNovo's (ASX:PNV) Returns On Capital
September 19, 2022 | fool.com.au
PolyNovo share price jumps 11% on FDA update
September 16, 2022 | fool.com.au
Polynovo share price halted amid FDA news
See More Headlines


Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
ASX:PNV
CUSIP
N/A
CIK
N/A
Web
www.polynovo.com.au
Phone
61 3 8681 4050
Fax
N/A
Employees
122
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
A($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
2.63
Net Income
$-6,630,000.00
Net Margins
-12.49%
Pretax Margin
N/A
Return on Equity
-15.99%
Return on Assets
-4.84%

Debt

Debt-to-Equity Ratio
28.44
Current Ratio
5.85
Quick Ratio
1.58

Sales & Book Value

Annual Sales
$53.12 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
207.50
Book Value
A$0.09 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
689,830,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.45

Key Executives

  • Mr. Jan-Marcel Gielen C.A.
    CFO & Company Sec.
  • Dr. David McQuillan Ph.D.
    Chief Technical & Scientific Officer
  • Mr. Swami Raote BPHARM
    M.B.A., CEO & Director
  • Mr. Ahmed Hassan
    Director of Operations
  • Ms. Teena Chadha
    APAC Marketing & Distributor Mang.
  • Ms. Monica Benyk
    HR Mang.
  • Dr. Tim Moore
    Principal Scientist
  • Mr. Edward Graubart
    Sr. VP of Sales & Marketing (Americas)

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













PNV Stock - Frequently Asked Questions

What other stocks do shareholders of PolyNovo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PolyNovo investors own include Immutep (IMMP), Rural Funds Group (RFF), Vanguard FTSE Pacific ETF (VPL), UQM Technologies (UQM), Tesla (TSLA), Starpharma (SPL), Moelis Australia (MOE), iSignthis (ISX), Align Technology (ALGN) and Acasti Pharma (ACST).

What is PolyNovo's stock symbol?

PolyNovo trades on the ASX under the ticker symbol "PNV."

How much money does PolyNovo make?

PolyNovo (ASX:PNV) has a market capitalization of $0.00 and generates $53.12 million in revenue each year. The company earns $-6,630,000.00 in net income (profit) each year or A($0.01) on an earnings per share basis.

How many employees does PolyNovo have?

The company employs 122 workers across the globe.

How can I contact PolyNovo?

The official website for the company is www.polynovo.com.au. The company can be reached via phone at 61 3 8681 4050.

This page (ASX:PNV) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -